McKesson Corporation provides healthcare services in the United States and
internationally. It operates through four segments: U.S. Pharmaceutical,
International, Medical-Surgical Solutions, and Prescription Technology
Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic,
specialty, biosimilar, and over-the-counter pharmaceutical drugs and other
healthcare-related products. This segment also provides practice management,
technology, clinical support, and business solutions to community-based
oncology and other specialty practices; and consulting, outsourcing,
technological, and other services, as well as sells financial, operational, and
clinical solutions to pharmacies. The International segment offers distribution
and services to wholesale, institutional, and retail customers in 13 European
countries and Canada. The Medical-Surgical Solutions segment provides medical-
surgical supply distribution, logistics, and other services to healthcare
providers. The RxTS segment serves biopharma and life sciences partners and
patients to address medication challenges for patients throughout their
journeys; connects pharmacies, providers, payers, and biopharma companies to
deliver innovative access and adherence solutions; and provides third-party
logistics and wholesale distribution support solutions. McKesson Corporation
was founded in 1833 and is headquartered in Irving, Texas.
